| Pharmaceutical active ingredients: |
| Prednisolone Sodium Phosphate |
| Available forms, composition and doses of Inflamase Mild: |
| Solution; Ophthalmic; Prednisolone Sodium Phosphate 0.125% |
| Inflamase Mild medical category: |
| Human:AdrenalsAnti-inflammatory agentsCorticosteroid hormonesEye corticosteroidsSulfonamidesTopical corticosteroidsTreatment of dermatological diseasesWeak (group I) corticosteroids |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A07EA01 - PrednisoloneC05AA04 - PrednisoloneD07AA03 - PrednisoloneD07XA02 - PrednisoloneH02AB06 - PrednisoloneR01AD02 - PrednisoloneS01BA04 - PrednisoloneS01CB02 - PrednisoloneS02BA03 - PrednisoloneS03BA02 - Prednisolone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| NovartisIolab Pharmaceuticals |
| Related documents and information about Inflamase Mild: |
| Inflamase Novartis prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Fisopred | Prednisolone Sodium Phosphate | Sanofi-Aventis |
| Hefasolon | Prednisolone Sodium Phosphate | Sanavita |
| Hydeltrasol | Prednisolone Sodium Phosphate | Merck |
| Inflamase | Prednisolone Sodium Phosphate | Novartis; Iolab Pharmaceuticals |
| Inflamase Forte | Prednisolone Sodium Phosphate | Novartis; Iolab Pharmaceuticals |
| Key-Pred-SP | Prednisolone Sodium Phosphate | Hyrex Pharmaceuticals |
| Liquisone | Prednisolone Sodium Phosphate | Lloyd's Laboratories; Remed Pharmaceuticals |
| Medopred | Prednisolone Sodium Phosphate | Medochemie |
| Medsone | Prednisolone Sodium Phosphate | Medhaus Pharma |
| Minims Prednisolone | Prednisolone Sodium Phosphate | Chauvin Pharmaceuticals; Bausch and Lomb; Pan-Malayan Pharmaceuticals; Rich Plan International |